Removing Regulatory Hurdles for Continuous Pharmaceutical Manufacturing
ISPE
JULY 5, 2023
13 An FDA-authored paper indicating support for the implementation of CM using science- and risk-based approaches followed soon thereafter. In addition to the FDA, health authorities in Canada, Europe, Australia, Japan, Switzerland, and New Zealand have also approved applications with CM for the production of solid oral dosage forms.
52 
Let's personalize your content